Impact of corticosteroids in hospitalised COVID-19 patients

BACKGROUND: Corticosteroids are a potential therapeutic agent for patients with COVID-19 pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data on the mortality benefits of corticosteroids. The study aimed to determine the association between corticosteroid use on mortal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open Respir Res
Main Authors: Ho, Kam Sing, Narasimhan, Bharat, Difabrizio, Larry, Rogers, Linda, Bose, Sonali, Li, Li, Chen, Roger, Sheehan, Jacqueline, El-Halabi, Maan Ajwad, Sarosky, Kimberly, Wang, Zichen, Eisenberg, Elliot, Powell, Charles, Steiger, David
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Respiratory Infection
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8023732/
https://ncbi.nlm.nih.gov/pubmed/33811098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjresp-2020-000766
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados